Malaria vaccine, Mosquirix, gets European nod

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2015

Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medi...Read more

Novavax's Ebola vaccine shows promise in human trial

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2015

Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early...Read more

No more needles, no more pain!

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2015

Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a...Read more

Shanghai BravoBio wins BioSpectrum award for role in China vaccine industry

Vaccines |  Influencers | By BioSpectrum Bureau  | 6 Comment | 15 Mar, 2013

Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign ma...Read more

WHO and World Food Program join forces to reach zero Ebola cases

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2015

Singapore: WHO and United Nations World Food Program (WFP) have come together to build logistics strength for Ebola-affe...Read more

FDA nod for Sanofi quadrivalent flu vaccine

Vaccines |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 11 Jun, 2013

Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain ...Read more

Vaccine for AIDS in ten years: Bill Gates

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2015

Singapore: With no cure or vaccine available for AIDS, that is spreading across the globe like a wide epidemic, billiona...Read more

AIDS 2014: Slash in fund jolts HIV research

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

Singapore: Investment in HIV prevention research has declined posing a challenge to the pipeline of HIV prevention produ...Read more

Novartis completes divestiture of influenza vaccines business

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

Singapore: Novartis has announced that it has completed the divestiture of its influenza vaccine unit to CSL Limited. Th...Read more

J&J's HIV vaccine to begin human trials

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2015

Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Jo...Read more

Agilent, A*Star, French univ sign biologics MoU

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology I...Read more

Stanford Univ reverse vaccine to treat diabetes

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

Singapore: Scientists at Stanford University, US, and Leiden University Medical Center in the Netherlands, have tested a...Read more

EU approves Merck's Keytruda for melanoma

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2015

Merck has announced that the European Commission has approved KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for the ...Read more

Astellas, ClearPath to enter strategic partnership

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jan, 2014

Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio ...Read more

Sanofi gears up to introduce dengue vaccine

Vaccines |  Influencers | By BioSpectrum Bureau  | 4 Comment | 15 Aug, 2014

Healthcare stakeholders are keeping high hopes with the successful results of Sanofi Pasteur's Phase III trial of dengue...Read more

India's vaccine future looks bright despite hurdles

Vaccines |  Analysis | By BioSpectrum Bureau  | 2 Comment | 24 Apr, 2013

The Indian vaccine industry has been in the past few years following close on the footsteps of the Indian pharma sector....Read more

HIV vaccine dream can now be a reality

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

Singapore: Scientists at Vaccine and Gene Therapy Institute of Florida (VGTI), US, a nonprofit immunological research in...Read more

Imaxio starts human trials with re-engineered TB antigen

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

Singapore: Vaccine firm Imaxio's proprietary pro-immunogenic technology, IMX313, has been administered for the first tim...Read more